Smarter imaging solutions for faster clinical trials

Multi-organ services delivered through quantitative MRI and DXA to support obesity, metabolic, and neuromuscular disease-focused clinical trials.

Accurate and precise non-invasive imaging biomarkers for characterizing and monitoring treatment response.

Accurate and precise non-invasive imaging biomarkers for characterizing and monitoring treatment response.

Rapid, high-quality sample processing with a fully digitized reporting workflow and quantitative AI-pathology

Integrated analysis of our noninvasive, multi-organ & tumor characterization software, digital pathology, and endoscopy, enables a deeper rapid analysis of the patient and their cancer.